Mark Estación

Gain of function Na _V 1.7 mutations in idiopathic small fiber neuropathy

Catharina G. Faber, Janneke G. J. Hoeijmakers, Hye‐Sook Ahn et al. · Annals of Neurology · 2011 · 540 citations

Gain-of-function mutations in sodium channel NaV1.9 in painful neuropathy

Jianying Huang, Chongyang Han, Mark Estación et al. · Brain · 2014 · 279 citations · Full text

Neuropathic Pain, Peripheral Nerve, Peripheral Nerves +18

Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial

Joanna M. Zakrzewska, Joanne Palmer, Valérie Morisset et al. · The Lancet Neurology · 2017 · 188 citations · Full text

Interventional Pain Medicine, Pain Medicine, Trigeminal Neuralgia +7

Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release

Aristos J. Alexandrou, Adam R. Brown, Mark L. Chapman et al. · PLoS ONE · 2016 · 187 citations · Full text

P2X7 Receptor-Dependent Blebbing and the Activation of Rho-Effector Kinases, Caspases, and IL-1β Release

Philip A. Verhoef, Mark Estación, William P. Schilling et al. · The Journal of Immunology · 2003 · 168 citations · Full text